Choice, transparency, coordination, and quality among direct-To-consumer telemedicine websites and apps treating skin disease

JAMA Dermatology

Volumn 152, Issue 7, 2016, Pages 768-775

  Resneck, Jack S ^a   Abrouk, Michael ^b   Steuer, Meredith ^b   Tam, Andrew ^b   Yen, Adam ^b   Lee, Ivy ^c   Kovarik, Carrie L ^d   Edison, Karen E ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Pasadena Premier Women's Health   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCREDITATION; ARTICLE; CLINICAL DECISION MAKING; CONTROLLED STUDY; DEMOGRAPHY; DERMATITIS; DIRECT-TO-CONSUMER ADVERTIZING; FEVER; FOLLICULITIS; GENERAL PRACTITIONER; HYPERTRICHOSIS; INTERNET; KAPOSI VARICELLIFORM ERUPTION; LICENSING; MEDICAL RECORD; MOBILE APPLICATION; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; SECONDARY SYPHILIS; SIMULATION; SKIN DISEASE; SKIN INFECTION; SKIN TUMOR; SMARTPHONE; TELEDERMATOLOGY; UNITED STATES; ADULT; ANAMNESIS; CONTRAINDICATIONS; DERMATOLOGIST; DERMATOLOGY; DIAGNOSTIC ERROR; ECONOMICS; FEMALE; HEALTH CARE QUALITY; HUMAN; INFORMATION PROCESSING; INTERPERSONAL COMMUNICATION; LEGISLATION AND JURISPRUDENCE; MALE; MIDDLE AGED; PATIENT CARE; PATIENT PREFERENCE; PATIENT SIMULATION; PROTOCOL COMPLIANCE; SKIN DISEASES; STANDARDS; TELEMEDICINE; YOUNG ADULT;

PRESCRIPTION DRUG;

ADULT; CONTINUITY OF PATIENT CARE; DATA COLLECTION; DERMATOLOGISTS; DERMATOLOGY; DIAGNOSTIC ERRORS; DISCLOSURE; FEMALE; GUIDELINE ADHERENCE; HUMANS; INTERNET; LICENSURE, MEDICAL; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; MOBILE APPLICATIONS; PATIENT PREFERENCE; PATIENT SIMULATION; PRESCRIPTION DRUGS; QUALITY OF HEALTH CARE; SKIN DISEASES; TELEMEDICINE; YOUNG ADULT;

EID: 84979674752     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2016.1774     Document Type: Article

References (17)

1. Warshaw EM, Gravely AA, Nelson DB. Reliability of store and forward teledermatology for skin neoplasms. J AmAcad Dermatol. 2015;72(3):426-435.
2. Edison KE, Ward DS, Dyer JA, Lane W, Chance L, Hicks LL. Diagnosis, diagnostic confidence, and management concordance in live-interactive and store-And-forward teledermatology compared to in-person examination. Telemed J E Health. 2008; 14(9):889-895.
3. Warshaw EM, Gravely AA, Bohjanen KA, et al. Interobserver accuracy of store and forward teledermatology for skin neoplasms. J AmAcad Dermatol. 2010;62(3):513-516.
4. Datta SK, Warshaw EM, Edison KE, et al. Cost and utility analysis of a store-And-forward teledermatology referral system: A randomized clinical trial. JAMA Dermatol. 2015;151(12):1323-1329.
5. Whited JD, Warshaw EM, Kapur K, et al. Clinical course outcomes for store and forward teledermatology versus conventional consultation: A randomized trial. J Telemed Telecare. 2013;19(4): 197-204.
6. Pak H, Triplett CA, Lindquist JH, Grambow SC, Whited JD. Store-And-forward teledermatology results in similar clinical outcomes to conventional clinic-based care. J Telemed Telecare. 2007;13(1): 26-30.
7. Digital Health Funding 2015 Year in Review. Rock Health. http://rockhealth.com/reports/digital-health-funding-2015-year-in-review/. Accessed March 31, 2016.
8. Dolan B. InDepth: The Changing Relationship of Health Plans and Virtual Visit Services. MobiHealth News. September 11, 2015. http://mobihealthnews.com/46676/in-depth-The-changing-relationship-of-health-plans-And-virtual-visit-services. Accessed March 31, 2016.
9. Huff C. AARP Bulletin. Medical Diagnosis by Webcam? Telemedicine exams are fast and easy-but questions remain. December 2015. http://www.aarp.org/health/conditions-Treatments/info-2015/telemedicine-health-symptoms-diagnosis.html. Accessed March 31, 2016.
10. Uscher-Pines L, Mulcahy A, Cowling D, Hunter G, Burns R, Mehrotra A. Access and quality of care in direct-To-consumer telemedicine. Telemed J E Health. 2016;22(4):282-287.
11. Kochmann M, Locatis C. Direct to consumer mobile teledermatology apps: An exploratory study [published online March 9, 2016]. Telemed J E Health. doi:10.1089/tmj.2015.0189.
12. Fogel AL, Sarin KY. A survey of direct-To-consumer teledermatology services available to US patients: explosive growth, opportunities and controversy [published online January 4, 2016]. J Telemed Telecare. doi:10.1177/1357633X15624044.
13. American Medical Association. H-480.946 Coverage of and payment for telemedicine. https://www.ama-Assn.org/ssl3/ecomm/PolicyFinderForm.pl?site=www.ama-Assn.org&uri=/resources/html/PolicyFinder/policyfiles/HnE/H-480.946.HTM. Accessed March 31, 2016.
14. American Academy of Dermatology Association. Position statement on teledermatology (amended March 7, 2016). https://www.aad.org/Forms/Policies/Uploads/PS/PS-Teledermatology.pdf. Accessed March 31, 2016.
15. Daniel H, Sulmasy LS; Health and Public Policy Committee of the American College of Physicians. Policy recommendations to guide the use of telemedicine in primary care settings: An American College of Physicians position paper. Ann Intern Med. 2015;163(10):787-789.
16. Marcin JP, Rimsza ME, Moskowitz WB; Committee on PediatricWorkforce. The use of telemedicine to address access and physician workforce shortages. Pediatrics. 2015;136(1):202-209.
17. American Medical Association. Code of Medical Ethics. Opinion 9.06-Free Choice. http://www.ama-Assn.org/ama/pub/physician-resources/medical-ethics/code-medical-ethics/opinion906.page. Accessed April 3, 2016.